William J. Muller, MD, PhD

Attending Physician, Infectious Diseases

Associate Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Clinical Interests: Infections in immune-compromised patients; infections with herpes group viruses

Specialties, Programs & Conditions

Specialties:

Pediatric Infectious Disease Treatment >

Education & Training

Education: Emory University School of Medicine, Atlanta, 2001

Postgraduate Training: Fellowship in pediatric infectious diseases, Children's Hospital and Regional Medical Center, Seattle, 2004-2007; Residency in pediatrics, Children's Hospital, Denver, 2001-2004

Board Certifications: Pediatric Infectious Diseases, General Pediatrics

Professional Organizations: American Academy of Pediatrics; American Medical Association; American Society for Microbiology; American Society of Transplantation; Infectious Diseases Society of America; Pediatric Infectious Diseases Society

Publications

Most recent publications

Treatment of perinatal viral infections to improve neurologic outcomes Pediatr Res
Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin beta receptor (LTbetaR) in human cells stimulated by the shared ligand LIGHT Mol Immunol62 (1): 96-103
Pathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation J Virol87 (1): 474-81
Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn Curr Immunol Rev6 (1): 38-55
Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage Sci Rep743712
IV pentamidine for Pneumocystis jiroveci pneumonia prophylaxis in pediatric allogeneic stem cell transplant patients Bone Marrow Transplant51 (10): 1394-1396
Preliminary Results From the US Zika Pregnancy Registry: Untangling Risks for Congenital Anomalies JAMA
Early viral suppression improves neurocognitive outcomes in HIV-infected children Aids29 (3): 295-304
Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy Rev Med Virol24 (5): 316-31
Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSV Pediatr Res76 (6): 528-34